Erratum
for
Le Cesne et al., J Clin Oncol 23 (3) 576-584.
Journal of Clinical Oncology, Vol 23, No 22 (August 1), 2005: pp. 5276
© 2005 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2005.05.943
ERRATUM
The January 20, 2005 article by Le Cesne et al titled, "Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial" (J Clin Oncol 23:576-584, 2005) contained an error.
The Authors Disclosures of Potential Conflicts of Interest section contained an omission by stating that there were no potential conflicts of interest. The full Authors Disclosures of Potential Conflicts of Interest section is as follows:
The following authors or their family members have indicated a financial interest. No conflict exists for drugs or devices used in a study if they are not being evaluated as part of the investigation. Employment: José Jimeno, PharmaMar. Leadership position: José Jimeno, Zeltia/PharmaMar. Stock ownership: José Jimeno, Zeltia/PharmaMar. For a detailed description of these categories, or for more information about ASCOs conflict of interest policy, please refer to the Author Disclosure Declaration and Disclosures of Potential Conflicts of Interest found in Information for Contributors in the front of each issue.

CiteULike Complore Connotea Del.icio.us Digg Facebook Reddit Technorati Twitter What's this?
|